Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-b1 and TNF-a
Artículo
![Thumbnail](/themes/Mirage2/images/cubierta.jpg)
Open/ Download
Publication date
2011Metadata
Show full item record
Cómo citar
Guerrero, Javier
Cómo citar
Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-b1 and TNF-a
Author
Abstract
In carcinomas such as those of breast, pancreas,
stomach, and colon, cancer cells support the expansion of
molecular and cellular stroma in a phenomenon termed
desmoplasia, which is characterized by a strong fibrotic
response. In the case of breast tissue, in which stroma is
mainly a fatty tissue, this response presumably occurs at
the expense of the adipose cells, the most abundant stromal
phenotype, generating a tumoral fibrous structure rich in
fibroblast-like cells. In this study, we aimed to determine
the cellular mechanisms by which factors present in the
media conditioned by MDA-MB-231 and MCF-7 human
breast cancer cell lines induce a reversion of adipose cells
to a fibroblastic phenotype. We demonstrated that soluble
factors generated by these cell lines stimulated the reversion
of mammary adipose phenotype evaluated as intracellular
lipid content and expression of C/EBPa and
PPARc. We also demonstrated that exogenous TGF-b1 and
TNF-a exerts a similar function. The participation of both
growth factors, components of media conditioned by
tumoral mammary cells, on the expression and nuclear
translocation of C/EBPa and PPARc was tested in 3T3-L1
cells by interfering with the inhibitory effects of media
with agents that block the TGF-b1 and TNF-a activity.
These results allow us to postulate that TGF-b1 and TNF-a
present in this media are in part responsible for this phenotypic
reversion.
General note
Artículo de publicación ISI
Patrocinador
This work was supported by the grant (1080196
to JM) from the Fondo Nacional de Ciencia y Tecnologı´a (FONDECYT)
of Chile.
Quote Item
Breast Cancer Res Treat (2010) 119:497–508. DOI 10.1007/s10549-009-0491-1
Collections